Summary

Japan Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others) -Forecast to 2035

Market Summary:
As per Market Research Future analysis, the percutaneous coronary-intervention market size was estimated at 438.6 USD Million in 2024. The percutaneous coronary-intervention market is projected to grow from 489.96 USD Million in 2025 to 1482.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 11.7% during the forecast period 2025 - 2035

Market Drivers:
Japan's increasing healthcare expenditure is a significant driver for the percutaneous coronary-intervention market. With healthcare spending projected to reach approximately $500 billion by 2026, there is a growing investment in advanced medical technologies and treatment options. This financial commitment allows healthcare facilities to acquire state-of-the-art equipment and provide high-quality care to patients. Furthermore, as the population ages and the burden of chronic diseases rises, the demand for effective interventions is likely to escalate. The willingness of both the government and private sectors to allocate resources towards cardiovascular care may enhance the growth prospects of the percutaneous coronary-intervention market, ensuring that patients have access to the latest treatment modalities. Technological innovations play a crucial role in shaping the percutaneous coronary-intervention market. In Japan, the introduction of advanced imaging techniques and minimally invasive devices has revolutionized the treatment landscape. For instance, the use of drug-eluting stents has improved patient outcomes and reduced the risk of restenosis.

Market Segment Analysis:
The Japan Percutaneous Coronary Intervention Market is experiencing noteworthy transformation driven by advancements in various product types utilized for interventional cardiology procedures. Among these, Coronary Stents stand out as pivotal elements due to their role in maintaining vessel patency, thereby significantly improving patient outcomes in coronary artery disease. The adoption of drug-eluting stents has particularly accelerated, as they effectively minimize the risk of restenosis, which is critical in enhancing long-term treatment success in Japan’s aging population that grapples with increasing cardiovascular ailments. Balloon Catheters are also fundamental to this market, primarily serving as key components during angioplasty procedures. Their efficacy in delivering precise balloon dilation to treat stenotic arteries amplifies their importance in interventional strategies. The Vascular Access segment of the Japan Percutaneous Coronary Intervention Market plays a crucial role in the effective execution of coronary procedures.

Regional Analysis:
The percutaneous coronary-intervention market in Japan is currently experiencing notable advancements, driven by a combination of technological innovations and an increasing prevalence of cardiovascular diseases. The aging population in Japan, coupled with lifestyle changes, has led to a rise in conditions such as coronary artery disease. As a result, healthcare providers are increasingly adopting minimally invasive procedures, which are perceived to offer quicker recovery times and reduced hospital stays. This shift towards less invasive techniques appears to be reshaping treatment protocols, as clinicians seek to enhance patient outcomes while managing healthcare costs effectively. Moreover, the regulatory environment in Japan is evolving to support the introduction of new devices and techniques in the percutaneous coronary-intervention market.

Major Players:
The following companies are key participants in the Japan Percutaneous Coronary Intervention Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Healthcare
Market Segmentation
Japan Healthcare By Application (USD Billion, 2025-2035)Coronary Artery Disease
Acute Coronary Syndrome
Stable Angina
Unstable Angina
Healthcare By Device Type (USD Billion, 2025-2035)Balloon Catheters
Stents
Guidewires
Sheaths
Healthcare
Japan By End User (USD Billion, 2025-2035)Hospitals
Cardiac Catheterization Labs
Ambulatory Surgical Centers
Healthcare By Procedure Type (USD Billion, 2025-2035)Elective Procedures
Emergency Procedures
Diagnostic Procedures SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the percutaneous coronary-intervention market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the percutaneous coronary-intervention market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Terum
Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Nippon Kayaku C
Ltd
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Asahi Intecc C
Ltd
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi Tanabe Pharma Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Kawasumi Laboratories Inc
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Japan Lifeline C
Ltd
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Medico's Hirata Inc
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Sanky
C
Ltd
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Terumo Corporation, Nippon Kayaku Co Ltd, Asahi Intecc Co Ltd, Mitsubishi Tanabe Pharma Corporation, Kawasumi Laboratories Inc, Japan Lifeline Co Ltd, Medico's Hirata Inc, Sankyo Co Ltd

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 3 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET ANALYSIS BY VASCULAR ACCESS
FIGURE 4 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET ANALYSIS BY END USER
FIGURE 5 KEY BUYING CRITERIA OF PERCUTANEOUS CORONARY-INTERVENTION MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS OF JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET
FIGURE 11 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
FIGURE 12 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
FIGURE 13 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY VASCULAR ACCESS, 2024 (% SHARE)
FIGURE 14 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY VASCULAR ACCESS, 2024 TO 2035 (USD Million)
FIGURE 15 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY END USER, 2024 (% SHARE)
FIGURE 16 JAPAN PERCUTANEOUS CORONARY-INTERVENTION MARKET, BY END USER, 2024 TO 2035 (USD Million)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan PERCUTANEOUS CORONARY-INTERVENTION MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 2 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 3 BY VASCULAR ACCESS, 2026-2035 (USD Million)
TABLE 4 BY VASCULAR ACCESS, 2026-2035 (USD Million)
TABLE 5 BY END USER, 2026-2035 (USD Million)
TABLE 6 BY END USER, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP